There’s no cure for dermatomyositis, but treatment can improve the skin, and muscle strength and function. The earlier treatment is started, the more effective it is, leading to fewer complications such as difficulty swallowing, breathing problems, and aspiration pneumonia. Even though it’s better to start treatment earlier rather than later, current treatments, including corticosteroids and immunosuppressive drugs, have demonstrated limited efficacy and serious side effects.
We recently initiated a Phase 2 clinical trial with IMO-8400 in patients with dermatomyositis.
More information about dermatomyositis and other forms of myositis is available on The Myositis Association’s website.
For more information on this study or study site locations, go to U.S. FDA Clinical Trial Registry Site, contact Idera at email@example.com, or visit Idera’s Clinical Trials site at Idera’s Clinical Trials Website.